Dosing chart / Growth hormone
Ipamorelin vs Hexarelin
Dose, schedule, route and approval status side by side.
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.
| Ipamorelin | Hexarelin | |
|---|---|---|
| Status | Not approved | Not approved |
| Also known as | – | examorelin |
| Typical dose | 100–300 mcg | 100–200 mcg |
| How often | Daily, 1–3 times | Daily, 1–3 times |
| Schedule | One to three times daily, commonly before bed. | One to three times daily. |
| Daily equivalent | 100–900 mcg/day | 100–600 mcg/day |
| Route | Subcutaneous | Subcutaneous |
| Duration | 8–12 weeks reported | 4–8 weeks reported |
| Notes | Growth hormone secretagogue. Reached Phase 2 for post-surgical bowel recovery but was not approved. | Response fades with continued use, so reported cycles are short. |
This page sets the two chart entries next to each other. It does not say which is better or whether either is right for you. Read member experiences on the Ipamorelin and Hexarelin pages.
Advertisement